Búsqueda | Portal de Búsqueda de la BVS España

1.

International Divergence in Gene Patenting.

Nicol, Dianne; Dreyfuss, Rochelle C; Gold, E Richard; Li, Wei; Liddicoat, John; Van Overwalle, Geertrui.

Annu Rev Genomics Hum Genet; 20: 519-541, 2019 08 31.

Artículo en Inglés | MEDLINE | ID: mdl-30786226

2.

The fall of the innovation empire and its possible rise through open science.

Gold, E Richard.

Res Policy; 50(5): 104226, 2021 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-34083844

3.

Accelerating Translational Research through Open Science: The Neuro Experiment.

Gold, E Richard.

PLoS Biol; 14(12): e2001259, 2016 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-27932848

4.

Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system.

Ali-Khan, Sarah E; Gold, E Richard.

Genet Med; 19(11): 1253-1259, 2017 11.

Artículo en Inglés | MEDLINE | ID: mdl-28492533

5.

Exploring regulatory flexibility to create novel incentives to optimize drug discovery.

Sullivan, Jacqueline A; Gold, E Richard.

Front Med (Lausanne); 11: 1379966, 2024.

Artículo en Inglés | MEDLINE | ID: mdl-38808140

6.

University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.

Herder, Matthew; Gold, E Richard; Murthy, Srinivas.

Healthc Policy; 17(4): 15-25, 2022 05.

Artículo en Inglés | MEDLINE | ID: mdl-35686821

7.

Authors' Response - A Status Quo of Failure: Time to Fix University Technology Transfer to Address Global Health.

Herder, Matthew; Gold, E Richard; Murthy, Srinivas.

Healthc Policy; 17(4): 45-47, 2022 05.

Artículo en Inglés | MEDLINE | ID: mdl-35686824

8.

Are patents impeding medical care and innovation?

Gold, E Richard; Kaplan, Warren; Orbinski, James; Harland-Logan, Sarah; N-Marandi, Sevil.

PLoS Med; 7(1): e1000208, 2010 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-20052274

9.

Myriad Genetics: In the eye of the policy storm.

Gold, E Richard; Carbone, Julia.

Genet Med; 12(4 Suppl): S39-70, 2010 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-20393310

10.

An open toolkit for tracking open science partnership implementation and impact.

Gold, E Richard; Ali-Khan, Sarah E; Allen, Liz; Ballell, Lluis; Barral-Netto, Manoel; Carr, David; Chalaud, Damien; Chaplin, Simon; Clancy, Matthew S; Clarke, Patricia; Cook-Deegan, Robert; Dinsmore, A P; Doerr, Megan; Federer, Lisa; Hill, Steven A; Jacobs, Neil; Jean, Antoine; Jefferson, Osmat Azzam; Jones, Chonnettia; Kahl, Linda J; Kariuki, Thomas M; Kassel, Sophie N; Kiley, Robert; Kittrie, Elizabeth Robboy; Kramer, Bianca; Lee, Wen Hwa; MacDonald, Emily; Mangravite, Lara M; Marincola, Elizabeth; Mietchen, Daniel; Molloy, Jennifer C; Namchuk, Mark; Nosek, Brian A; Paquet, Sébastien; Pirmez, Claude; Seyller, Annabel; Skingle, Malcolm; Spadotto, S Nicole; Staniszewska, Sophie; Thelwall, Mike.

Gates Open Res; 3: 1442, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31850398

11.

Biotechnology patents: strategies for meeting economic and ethical concerns.

Gold, E Richard.

Nat Genet; 30(4): 359, 2002 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-11925560

12.

Identifying the challenges in implementing open science [version 1; peer review: 2 approved].

Ali-Khan, Sarah E; Jean, Antoine; Gold, E Richard.

MNI Open Res; 2: 5, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-33937623

13.

Defining Success in Open Science [version 2; peer review:2 approved].

Ali-Khan, Sarah E; Jean, Antoine; MacDonald, Emily; Gold, E Richard.

MNI Open Res; 2: 2, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-33937622

14.

Defining Success in Open Science.

Ali-Khan, Sarah E; Jean, Antoine; MacDonald, Emily; Gold, E Richard.

MNI Open Res; 2: 2, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-29553146

15.

What the COVID-19 pandemic revealed about intellectual property.

Gold, E Richard.

Nat Biotechnol; 40(10): 1428-1430, 2022 10.

Artículo en Inglés | MEDLINE | ID: mdl-36207587

16.

Motivating participation in open science by examining researcher incentives.

Ali-Khan, Sarah E; Harris, Liam W; Gold, E Richard.

Elife; 62017 10 30.

Artículo en Inglés | MEDLINE | ID: mdl-29082866

17.

More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies?

Bubela, Tania; Bonter, Katherine; Lachance, Silvy; Delisle, Jean-Sébastien; Gold, E Richard.

Front Med (Lausanne); 4: 134, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-28861415

18.

The missing ingredient in medicine patent pools.

Gold, E Richard; Morin, Jean-Frédéric.

Lancet; 374(9698): 1329-30, 2009 Oct 17.

Artículo en Inglés | MEDLINE | ID: mdl-19837251

19.

Gene patents--more evidence needed, but policymakers must act.

Gold, E Richard; Bubela, Tania; Miller, Fiona A; Nicol, Dianne; Piper, Tina.

Nat Biotechnol; 25(4): 388-9, 2007 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-17420737

20.

Needed: models of biotechnology intellectual property.

Gold, E Richard; Castle, David; Cloutier, L Martin; Daar, Abdallah S; Smith, Pamela J.

Trends Biotechnol; 20(8): 327-9, 2002 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12127278

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

International Divergence in Gene Patenting.

The fall of the innovation empire and its possible rise through open science.

Accelerating Translational Research through Open Science: The Neuro Experiment.

Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system.

Exploring regulatory flexibility to create novel incentives to optimize drug discovery.

University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.

Authors' Response - A Status Quo of Failure: Time to Fix University Technology Transfer to Address Global Health.

Are patents impeding medical care and innovation?

Myriad Genetics: In the eye of the policy storm.

An open toolkit for tracking open science partnership implementation and impact.

Biotechnology patents: strategies for meeting economic and ethical concerns.

Identifying the challenges in implementing open science [version 1; peer review: 2 approved].

Defining Success in Open Science [version 2; peer review:2 approved].

Defining Success in Open Science.

What the COVID-19 pandemic revealed about intellectual property.

Motivating participation in open science by examining researcher incentives.

More Haste, Less Speed: Could Public-Private Partnerships Advance Cellular Immunotherapies?

The missing ingredient in medicine patent pools.

Gene patents--more evidence needed, but policymakers must act.

Needed: models of biotechnology intellectual property.